Alkermes Plc (NASDAQ:ALKS)

22.30
Delayed Data
As of Sep 13
 -0.32 / -1.41%
Today’s Change
19.36
Today|||52-Week Range
45.16
-24.43%
Year-to-Date
No recent news for Alkermes Plc.

Today’s Trading

Previous close22.62
Today’s open22.52
Day’s range21.67 - 22.83
Volume1,755,524
Average volume (3 months)1,314,088
Market cap$3.5B
Data as of 3:59pm ET, 09/13/2019

Growth & Valuation

Earnings growth (last year)+12.81%
Earnings growth (this year)-40.83%
Earnings growth (next 5 years)+30.74%
Revenue growth (last year)+21.13%
P/E ratioNM
Price/Sales4.18
Price/Book2.97

Competitors

 Today’s
change
Today’s
% change
MDCOMedicines Co-0.78-1.61%
MRTXMirati Therapeutics ...+0.84+0.99%
RAREUltragenyx Pharmaceu...-0.59-1.32%
UTHRUnited Therapeutics ...+0.87+1.09%
Data as of 4:00pm ET, 09/13/2019

Financials

Next reporting dateOctober 28, 2019
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$1.1B
Annual profit (last year)-$139.3M
Net profit margin-12.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
Chief Financial Officer &
Senior Vice President
Jim Frates
Corporate headquarters
Dublin, Dublin

Forecasts